CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 649 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04833556
NCT04833556N/ACompleted

Clinical Characteristics and Perioperative Outcomes of Postpartum Hemorrhage in Patients Undergoing Cesarean Delivery

Mahidol University·observational·Posted Apr 6, 2021·Updated Dec 22, 2025

In Brief

An observational study for Cesarean Section Complications and 4 related conditions. Completed, enrolled 649 participants across 1 site.

Detailed Summary

Postpartum haemorrhage is the common cause of maternal death worldwide. The primary purpose of this study is to identify the maternal outcomes after PPH. The highlighted outcome is the anesthetic management including rate of blood transfusion and incidence of patient experiencing massive blood transfusion. The secondary purposes of this study are amount of blood loss, causes of PPH and other outcomes that related to PPH such as the rate of hysterectomy and postoperative outcome eg. congestive heart failure, acute kidney injury and TRALI etc. Additionally, incidence of PPH will be studied. Data collection will be made to identify the cause of PPH, anesthetic techniques that may related to the amount of hemorrhage, medical treatment for PPH and neonatal outcomes. We also aim to obtain the rate of ICU admission and revealed the factors involving the ICU admission in PPH patients underwent cesarean delivery.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesThailand
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 6, 2021
Enrollment StartApr 22, 2021
Primary CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 5.2 years ago